NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure

NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure

Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.

Propose adaptations to HACOR score based on the "state of art" of COVID-19

Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in patients with COVID-19 associated respiratory failure.

Propose adaptations to HACOR score based on the "state of art" of COVID-19

- this adaptations may include radiologic aggravation and monitoring of CRF, ferritin, LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count

Inclusion Criteria:

• Patients with acute respiratory failure due to COVID-19 who have initiated NIV or CPAP based on assistant clinician decision

Exclusion Criteria:

• Patients with imediate indication to invasive mechanical ventilation
• Patients with any formal contraindication to noninvasive respiratory support